Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥660,000)
Fiscal Year 2009: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2008: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2007: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
Research Abstract |
1) We have been developing the recombinant HSV, which has the promotor region targeted on prostate specific membrane (PSM). 2) We have found that one of the two splice variant of surviving, survivin-Ex3 has a positive, and the other splice variant survivin-2B has a negative correlation with histological grade. 3) We have been developing the recombinant HSV, which has the promotor region targeted on Survivin-Ex3.
|